Related Experiment Video
Updated: Mar 9, 2026
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine
Martin P Grobusch1, Abraham Goorhuis2
1Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Lion Heart Medical Research Unit, Yele, Sierra Leone.
No abstract available in PubMed .
More Related Videos
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
